Published on 17 Oct 2024 on Benzinga · via AOL
FDA Approves AbbVie's Parkinson's Treatment, Medicare Coverage Expected Next...
On Thursday, the FDA approved AbbVie Inc’s (NYSE:ABBV) Vyalev (foscarbidopa and foslevodopa) as the...
NYSE.ABBV price evolution
Want to become a better investor?
Start tracking your investments with Statfolio
Sign up for free